Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-Fluorocholine PET/MRI for the Localization of Parathyroid Adenomas

NCT03324893 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03324893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03324893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-Fluorocholine PET/MRI for the Localization of Parathyroid Adenomas
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2018
Completion date
June 23, 2021
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

18f-fluorocholine, hyperparathyroidism, primary, positron-emission tomography